HRP20190023T1 - Pripravak za kontroliranu stimulaciju jajnika - Google Patents

Pripravak za kontroliranu stimulaciju jajnika

Info

Publication number
HRP20190023T1
HRP20190023T1 HRP20190023TT HRP20190023T HRP20190023T1 HR P20190023 T1 HRP20190023 T1 HR P20190023T1 HR P20190023T T HRP20190023T T HR P20190023TT HR P20190023 T HRP20190023 T HR P20190023T HR P20190023 T1 HRP20190023 T1 HR P20190023T1
Authority
HR
Croatia
Prior art keywords
composition
ovarian stimulation
controlled ovarian
controlled
stimulation
Prior art date
Application number
HRP20190023TT
Other languages
English (en)
Inventor
Joan-Carles Arce
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46785372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20190023(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of HRP20190023T1 publication Critical patent/HRP20190023T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HRP20190023TT 2011-08-08 2019-01-03 Pripravak za kontroliranu stimulaciju jajnika HRP20190023T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11176803 2011-08-08
EP14184409.2A EP2821080B1 (en) 2011-08-08 2012-08-08 Composition for controlled ovarian stimulation

Publications (1)

Publication Number Publication Date
HRP20190023T1 true HRP20190023T1 (hr) 2019-02-22

Family

ID=46785372

Family Applications (8)

Application Number Title Priority Date Filing Date
HRP20240420TT HRP20240420T1 (hr) 2011-08-08 2012-08-08 Pripravak za kontroliranu stimulaciju jajnika
HRP20230607TT HRP20230607T1 (hr) 2011-08-08 2012-08-08 Pripravak za kontroliranu stimulaciju jajnika
HRP20160145TT HRP20160145T1 (hr) 2011-08-08 2016-02-09 Pripravak za kontroliranu stimulaciju jajnika
HRP20181639TT HRP20181639T1 (hr) 2011-08-08 2018-10-10 Pripravak za kontroliranu stimulaciju jajnika
HRP20190023TT HRP20190023T1 (hr) 2011-08-08 2019-01-03 Pripravak za kontroliranu stimulaciju jajnika
HRP20191437 HRP20191437T1 (hr) 2011-08-08 2019-08-08 Sastav za kontroliranu stimulaciju jajnika
HRP20210277TT HRP20210277T1 (hr) 2011-08-08 2021-02-18 Pripravak za kontroliranu stimulaciju jajnika
HRP20210722TT HRP20210722T1 (hr) 2011-08-08 2021-05-10 Pripravak za kontroliranu stimulaciju jajnika

Family Applications Before (4)

Application Number Title Priority Date Filing Date
HRP20240420TT HRP20240420T1 (hr) 2011-08-08 2012-08-08 Pripravak za kontroliranu stimulaciju jajnika
HRP20230607TT HRP20230607T1 (hr) 2011-08-08 2012-08-08 Pripravak za kontroliranu stimulaciju jajnika
HRP20160145TT HRP20160145T1 (hr) 2011-08-08 2016-02-09 Pripravak za kontroliranu stimulaciju jajnika
HRP20181639TT HRP20181639T1 (hr) 2011-08-08 2018-10-10 Pripravak za kontroliranu stimulaciju jajnika

Family Applications After (3)

Application Number Title Priority Date Filing Date
HRP20191437 HRP20191437T1 (hr) 2011-08-08 2019-08-08 Sastav za kontroliranu stimulaciju jajnika
HRP20210277TT HRP20210277T1 (hr) 2011-08-08 2021-02-18 Pripravak za kontroliranu stimulaciju jajnika
HRP20210722TT HRP20210722T1 (hr) 2011-08-08 2021-05-10 Pripravak za kontroliranu stimulaciju jajnika

Country Status (31)

Country Link
US (4) US9694052B2 (hr)
EP (9) EP2821080B1 (hr)
JP (5) JP6161609B2 (hr)
KR (7) KR102499969B1 (hr)
CN (2) CN107281470A (hr)
AR (1) AR087476A1 (hr)
AU (3) AU2012293647B2 (hr)
BR (2) BR112014002884A2 (hr)
CA (1) CA2844282A1 (hr)
CY (1) CY1117214T1 (hr)
DK (8) DK3195875T3 (hr)
ES (8) ES2742163T3 (hr)
FI (2) FI4005588T3 (hr)
HK (2) HK1198005A1 (hr)
HR (8) HRP20240420T1 (hr)
HU (8) HUE053716T2 (hr)
IL (2) IL300380A (hr)
JO (1) JO3092B1 (hr)
LT (7) LT3395357T (hr)
MX (4) MX348981B (hr)
PL (8) PL3195875T3 (hr)
PT (6) PT3646881T (hr)
RS (8) RS64328B1 (hr)
RU (2) RU2739037C3 (hr)
SA (1) SA112330762B1 (hr)
SI (8) SI3756681T1 (hr)
SM (1) SMT201600038B (hr)
TR (2) TR201900071T4 (hr)
TW (2) TWI657822B (hr)
WO (1) WO2013020996A1 (hr)
ZA (2) ZA201400952B (hr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
JP2018500934A (ja) * 2014-12-22 2018-01-18 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Cmp依存性シアリダーゼ活性
DK3283097T3 (da) * 2015-04-17 2020-04-20 Ferring Bv Fsh til behandling af infertilitet
WO2016207353A1 (en) 2015-06-26 2016-12-29 Ferring B.V. Methods of purification and/or viral inactivation
CN113198005B (zh) * 2015-09-17 2024-09-06 广州汉腾生物科技有限公司 具有提高的稳定性的哺乳动物促卵泡激素组合物
TWI778979B (zh) * 2016-09-30 2022-10-01 瑞士商麥歐文科學有限公司 治療女性不孕症之方法
JOP20200034A1 (ar) 2017-09-01 2020-02-13 Ferring Bv تركيبة للتنشيط المتحكم فيه للمبيض
JP2021522268A (ja) 2018-04-30 2021-08-30 フェリング ベスローテン フェンノートシャップ 制御された卵巣刺激のための組成物
TWI846743B (zh) 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
US11576920B2 (en) 2019-03-18 2023-02-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
CN110841060A (zh) * 2019-11-21 2020-02-28 上海交通大学 Choriogonadotropin alfa在治疗多囊卵巢综合征中的应用
TW202237173A (zh) 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
AU2022451605A1 (en) 2022-04-01 2024-09-26 Ferring B.V. Mixed protocol for treatment of infertility
WO2023227761A1 (en) 2022-05-26 2023-11-30 Ferring B.V. Compositions and methods for treatment of infertility in males
WO2024008971A1 (en) 2022-07-08 2024-01-11 Ferring B.V. Compositions and methods for intrauterine insemination (iui)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL122732A0 (en) 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
EP1074265A1 (en) * 1999-08-03 2001-02-07 Erasmus Universiteit Rotterdam Use of AMH and/or AMH agonists and/or AMH antagonists for long-term control of female fertility
CN1608078B (zh) * 2001-10-22 2012-07-25 默克雪兰诺有限公司 用于卵泡生成的促性腺激素
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
US8501719B2 (en) * 2005-11-08 2013-08-06 American Infertility Of New York Androgen treatment in females
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
EP2417982A1 (en) 2010-07-30 2012-02-15 Ferring B.V. Stabilization of gonadotropins
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone
SI2621517T2 (sl) * 2010-09-29 2023-11-30 Ferring B.V. Sestavek za uporabo pri zdravljenju neplodnosti
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض

Also Published As

Publication number Publication date
MX2014001489A (es) 2014-04-25
PL3395357T3 (pl) 2019-11-29
SI3395357T1 (sl) 2019-09-30
MX2024008826A (es) 2024-07-25
TR201911269T4 (tr) 2019-08-21
HRP20210722T1 (hr) 2021-06-11
HUE054312T2 (hu) 2021-08-30
US20180028620A1 (en) 2018-02-01
SI2821080T1 (sl) 2019-01-31
EP3756681B1 (en) 2023-05-03
KR102111514B1 (ko) 2020-05-18
RS59107B1 (sr) 2019-09-30
FI4005588T3 (fi) 2024-05-15
AU2012293647B2 (en) 2016-10-06
RS61672B1 (sr) 2021-04-29
HUE040058T2 (hu) 2019-02-28
ES2742163T3 (es) 2020-02-13
EP3756681A1 (en) 2020-12-30
IL230696B1 (en) 2023-03-01
JP2019077693A (ja) 2019-05-23
PL4005588T3 (pl) 2024-06-10
PT2821080T (pt) 2018-12-17
ZA201506382B (en) 2017-01-25
EP3395357B1 (en) 2019-05-15
DK3566712T3 (da) 2021-04-19
ZA201400952B (en) 2022-03-30
RS58198B1 (sr) 2019-03-29
ES2977682T3 (es) 2024-08-28
TWI555530B (zh) 2016-11-01
ES2692774T3 (es) 2018-12-05
PL3566712T3 (pl) 2021-07-12
IL300380A (en) 2023-04-01
DK3395357T3 (da) 2019-08-19
DK3195875T3 (en) 2018-11-12
LT2821080T (lt) 2019-01-10
SI2741763T1 (sl) 2016-02-29
KR20230024442A (ko) 2023-02-20
PL3756681T3 (pl) 2023-08-21
LT3195875T (lt) 2018-11-12
HRP20240420T1 (hr) 2024-06-21
SI4005588T1 (sl) 2024-06-28
ES2562648T3 (es) 2016-03-07
MX2020010991A (es) 2020-11-09
HUE044610T2 (hu) 2019-11-28
NZ620369A (en) 2015-12-24
US20220370567A1 (en) 2022-11-24
JP2023134561A (ja) 2023-09-27
PT4005588T (pt) 2024-04-24
US11291708B2 (en) 2022-04-05
DK4005588T5 (da) 2024-08-05
BR112014002884A2 (pt) 2017-02-21
KR102499969B1 (ko) 2023-02-14
RS61843B1 (sr) 2021-06-30
AU2016273925A1 (en) 2017-01-12
DK2821080T3 (en) 2019-01-28
LT3566712T (lt) 2021-03-10
IL230696A0 (en) 2014-03-31
HRP20160145T1 (hr) 2016-04-08
WO2013020996A1 (en) 2013-02-14
AU2012293647A1 (en) 2014-02-27
EP3646881A1 (en) 2020-05-06
PT3395357T (pt) 2019-08-27
LT3756681T (lt) 2023-07-25
LT3395357T (lt) 2019-08-26
PL3646881T3 (pl) 2021-11-02
FI3756681T3 (fi) 2023-07-28
CY1117214T1 (el) 2017-04-05
AU2018203222A1 (en) 2018-05-24
EP3195875B1 (en) 2018-07-25
RS54561B1 (en) 2016-06-30
PL2741763T3 (pl) 2016-07-29
MX2024008825A (es) 2024-07-25
SMT201600038B (it) 2016-02-25
KR20200121918A (ko) 2020-10-26
JP2014522871A (ja) 2014-09-08
KR20210099162A (ko) 2021-08-11
KR20190100449A (ko) 2019-08-28
US20140329748A1 (en) 2014-11-06
HUE053716T2 (hu) 2021-07-28
RU2613324C3 (ru) 2021-06-09
JP2017141253A (ja) 2017-08-17
US20200345814A1 (en) 2020-11-05
DK4005588T3 (da) 2024-04-29
HUE041769T2 (hu) 2019-05-28
ES2884947T3 (es) 2021-12-13
DK3756681T3 (da) 2023-07-31
KR102014469B1 (ko) 2019-08-26
EP3195875A1 (en) 2017-07-26
JP6161609B2 (ja) 2017-07-12
AR087476A1 (es) 2014-03-26
US9694052B2 (en) 2017-07-04
MX348981B (es) 2017-07-06
RU2739037C3 (ru) 2021-09-08
RU2613324C2 (ru) 2017-03-15
EP2821080A1 (en) 2015-01-07
KR20140054191A (ko) 2014-05-08
EP4005588B1 (en) 2024-02-07
JO3092B1 (ar) 2017-03-15
AU2018203222B2 (en) 2020-03-12
SA112330762B1 (ar) 2015-10-08
TW201309322A (zh) 2013-03-01
DK3646881T3 (da) 2021-07-26
TR201900071T4 (tr) 2019-01-21
PT3195875T (pt) 2018-10-31
LT4005588T (lt) 2024-03-25
SI3195875T1 (sl) 2018-11-30
TW201716082A (zh) 2017-05-16
EP3566712A1 (en) 2019-11-13
HUE066158T2 (hu) 2024-07-28
HUE062640T2 (hu) 2023-11-28
RU2739037C2 (ru) 2020-12-21
SI3756681T1 (sl) 2023-08-31
CA2844282A1 (en) 2013-02-14
IL230696B2 (en) 2023-07-01
EP4306174A2 (en) 2024-01-17
RU2017106756A3 (hr) 2020-07-09
HK1204923A1 (en) 2015-12-11
EP4306174A3 (en) 2024-04-10
HRP20181639T1 (hr) 2018-12-14
TWI657822B (zh) 2019-05-01
JP6500050B2 (ja) 2019-04-10
PL2821080T3 (pl) 2019-04-30
ES2950911T3 (es) 2023-10-16
RS57897B1 (sr) 2019-01-31
AU2016273925B2 (en) 2018-03-15
EP2741763B1 (en) 2015-11-18
HUE027674T2 (en) 2016-11-28
EP3395357A1 (en) 2018-10-31
PT3646881T (pt) 2021-06-02
ES2704878T3 (es) 2019-03-20
CN103732243A (zh) 2014-04-16
EP2741763A1 (en) 2014-06-18
EP2821080B1 (en) 2018-10-10
RS64328B1 (sr) 2023-08-31
SI3566712T1 (sl) 2021-04-30
BR122020001644B1 (pt) 2022-08-02
RU2014102924A (ru) 2015-09-20
PT3756681T (pt) 2023-07-25
EP3646881B1 (en) 2021-04-28
EP4005588A1 (en) 2022-06-01
KR20210143934A (ko) 2021-11-29
JP2020147600A (ja) 2020-09-17
PL3195875T3 (pl) 2019-01-31
JP6718951B2 (ja) 2020-07-08
DK3756681T5 (da) 2024-08-26
JP7309660B2 (ja) 2023-07-18
HRP20210277T1 (hr) 2021-04-02
HK1198005A1 (zh) 2015-03-06
ES2871405T3 (es) 2021-10-28
SI3646881T1 (sl) 2021-08-31
KR20190140098A (ko) 2019-12-18
US10624953B2 (en) 2020-04-21
DK2741763T3 (da) 2016-02-15
HRP20230607T1 (hr) 2023-09-29
HRP20191437T1 (hr) 2019-11-15
LT3646881T (lt) 2021-05-25
KR102353144B1 (ko) 2022-01-18
CN107281470A (zh) 2017-10-24
EP3566712B1 (en) 2021-01-27
RU2017106756A (ru) 2019-01-23
RS65485B1 (sr) 2024-05-31

Similar Documents

Publication Publication Date Title
HRP20190023T1 (hr) Pripravak za kontroliranu stimulaciju jajnika